Title : A Possible Role for HMG-CoA Reductase Inhibitors and Its Association with HMGCR Genetic Variation in Parkinson's Disease.

Pub. Date : 2021 Nov 11

PMID : 34830081






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Neuroprotective effects of 3-hydroxy-3-methyl-glutaryl-coenzyme A (HMG-CoA) reductase inhibitors-statins-via both cholesterol-dependent and independent mechanisms have been shown in animal and cell culture models. Cholesterol 3-hydroxy-3-methylglutaryl-CoA reductase Homo sapiens
2 We present possible statin effects on PD under the hypothesis that they may depend on the HMG-CoA reductase gene (HMGCR) variability, such as haplotype 7, which was shown to affect cholesterol synthesis and statin treatment outcome, diminishing possible neuroprotection associated with HMG-CoA reductase inhibitors administration. Cholesterol 3-hydroxy-3-methylglutaryl-CoA reductase Homo sapiens
3 We present possible statin effects on PD under the hypothesis that they may depend on the HMG-CoA reductase gene (HMGCR) variability, such as haplotype 7, which was shown to affect cholesterol synthesis and statin treatment outcome, diminishing possible neuroprotection associated with HMG-CoA reductase inhibitors administration. Cholesterol 3-hydroxy-3-methylglutaryl-CoA reductase Homo sapiens